Related references
Note: Only part of the references are listed.(Q)SAR Modelling and Safety Assessment in Regulatory Review
N. L. Kruhlak et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
In Silico Assay for Assessing Phospholipidosis Potential of Small Drug like Molecules: Training, Validation, and Refinement Using Several Data Sets
Holger Fischer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
Umesh M. Hanumegowda et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Predicting Phospholipidosis Using Machine Learning
Robert Lowe et al.
MOLECULAR PHARMACEUTICS (2010)
Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
Jens-Uwe Peters et al.
CHEMMEDCHEM (2009)
Medicinal Chemistry Strategies to Minimize Phospholipidosis
Andrew J. Ratcliffe
CURRENT MEDICINAL CHEMISTRY (2009)
Weka Machine Learning for Predicting the Phospholipidosis Inducing Potential
Ovidiu Ivanciuc
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Computational toxicology in drug development
Wolfgang Muster et al.
DRUG DISCOVERY TODAY (2008)
MultiCASE expert systems and the REACH initiative
Roustem D. Saiakhov et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
In silico screening of chemicals for genetic toxicity using MDL-QSAR, nonparametric discriminant analysis, e-state, connectivity, and molecular property descriptors
Joseph F. Contrera et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models
Naomi L. Kruhlak et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Combined use of MC4PC, MDL-QSAR, BioEpisteme, leadscope PDM, and derek for windows software to achieve high-performance, high-confidence, mode of action-based predictions of chemical carcinogenesis in rodents
Edwin J. Matthews et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
In silico tools for sharing data and knowledge on toxicity and metabolism: Derek for windows, meteor, and vitic
Carol A. Marchant et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Drug-induced Phospholipidosis-Pathological Aspects and Its Prediction
Takashi Nonoyama et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2008)
Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models
Joseph F. Contrera et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
Evaluation of a published in silico model and construction of a novel bayesian model for predicting phospholipidosis inducing potential
Dennis J. Pelletier et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products
Naomi L. Kruhlak et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Drug-induced phospholipidosis
Nora Anderson et al.
FEBS LETTERS (2006)
In vitro assays and biomarkers for drug-induced phospholipidosis
David K. Monteith et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Drug-induced phospholipidosis: issues and future directions
Mark J. Reasor et al.
EXPERT OPINION ON DRUG SAFETY (2006)
An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods
EJ Matthews et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Finding discriminating structural features by reassembling common building blocks
KP Cross et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
